Literature DB >> 1316548

Characterization of 1,25-dihydroxyvitamin D3 receptor interactions with target sequences in the rat osteocalcin gene.

M B Demay1, M S Kiernan, H F DeLuca, H M Kronenberg.   

Abstract

The sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] receptor and mediate its effects on gene transcription contain three copies of a motif homologous to those found in other steroid response elements. To evaluate the relative importance of these motifs and their flanking sequences, functional properties and receptor binding of a series of mutant response elements were analyzed. Mutations in the third motif, including its deletion, have no effect on receptor binding and only modestly detrimental effects on the ability of the upstream motifs to confer 1,25-(OH)2D3 responsiveness in transfected cells. Mutations in the first two motifs have negative effects on both receptor binding and gene activation. Mutagenesis of bases upstream from each of the first two motifs alters receptor binding and gene activation; these bases are, therefore, an integral part of the rat osteocalcin 1,25-(OH)2D3 response element. Two direct hexameric repeats (GGGTGA ATG AGGACA) and not the palindromic motif thus characterize this 1,25-(OH)2D3 response element.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316548     DOI: 10.1210/mend.6.4.1316548

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  10 in total

Review 1.  Tissue specific and vitamin D responsive gene expression in bone.

Authors:  C White; E Gardiner; J Eisman
Journal:  Mol Biol Rep       Date:  1998-01       Impact factor: 2.316

Review 2.  The osteocalcin gene: a model for multiple parameters of skeletal-specific transcriptional control.

Authors:  G S Stein; J B Lian; A J van Wijnen; J L Stein
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

Review 3.  Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation.

Authors:  J B Lian; G S Stein
Journal:  Iowa Orthop J       Date:  1995

4.  In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells.

Authors:  E C Breen; A J van Wijnen; J B Lian; G S Stein; J L Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements.

Authors:  M Baes; T Gulick; H S Choi; M G Martinoli; D Simha; D D Moore
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

6.  BsmI-ApaI-TaqI TAC (BAt) Haplotype of Vitamin D Receptor Gene Is Associated with Increased Risk of Major Depressive Disorder.

Authors:  Munn-Sann Lye; Yin-Sim Tor; Yin-Yee Tey; Aishah Shahabudin; Su-Peng Loh; Normala Ibrahim; Johnson Stanslas; Rozita Rosli; King-Hwa Ling
Journal:  J Mol Neurosci       Date:  2020-10-09       Impact factor: 3.444

7.  Lymphoid enhancer-binding factor-1 (LEF1) interacts with the DNA-binding domain of the vitamin D receptor.

Authors:  Hilary F Luderer; Francesca Gori; Marie B Demay
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

8.  Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins.

Authors:  S R Patel; H Q Ke; R Vanholder; R J Koenig; C H Hsu
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Vitamin D Receptor in LS180 Human Colorectal Adenocarcinoma Cells.

Authors:  Kathleen G Barrett; Hailin Fang; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2016-04-29       Impact factor: 3.922

Review 10.  Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.

Authors:  S Christakos; M Raval-Pandya; R P Wernyj; W Yang
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.